INS and type 2 diabetes mellitus: For example, PPAR agonists were shown to increase mitochondrial content and oxidative capacity, in the livers of pre-diabetic mice [75], in adipose tissue [76] and skeletal muscle of insulin resistant and T2D patients [76,77] and mice [78], and these mitochondrial adaptations were accompanied by improvements in systemic insulin sensitivity.